3D細胞培養の世界市場:技術別(スキャフォールドベース、スキャフォールドフリー、バイオリアクター)、用途別(がん、医薬品開発)、最終用途別、地域別

【英語タイトル】3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free, Bioreactors), By Application (Cancer, Drug Development), By End Use, By Region, And Segment Forecasts, 2020 - 2027

Grand View Researchが出版した調査資料(GVR20MA084)・商品コード:GVR20MA084
・発行会社(調査会社):Grand View Research
・発行日:2020年2月11日
・ページ数:126
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、3D細胞培養の世界市場について調査・分析し、エグゼクティブサマリ、調査手法、市場の要因・動向・範囲、技術別(スキャフォールドベース、スキャフォールドフリー、バイオリアクター)分析、用途別(がん、組織工学&免疫組織化学、幹細胞研究、医薬品開発、その他)分析、エンドユーザー別(バイオテクノロジー&製薬産業、調査研究室&研究所、病院&診断センター、その他)分析、地域別分析、競争状況などの構成でお届けいたします。
・エグゼクティブサマリー
・調査手法
・市場の要因・動向・範囲
・3D細胞培養の世界市場:技術別(スキャフォールドベース、スキャフォールドフリー、バイオリアクター)
・3D細胞培養の世界市場:用途別(がん、組織工学&免疫組織化学、幹細胞研究、医薬品開発、その他)
・3D細胞培養の世界市場:エンドユーザー別(バイオテクノロジー&製薬産業、調査研究室&研究所、病院&診断センター、その他)
・3D細胞培養の世界市場:地域別
・競争状況
【レポートの概要】

The global 3D cell culture market size is expected to reach USD 3.2 billion by 2027, expanding at a CAGR of 11.3%, according to a new report by Grand View Research, Inc. A rise in the adoption of in-vivo models for a better understanding of cell behavior is anticipated to fuel market growth.

Expected emergence of 3D optimized kits, protocols, and assays and evolution of different assay techniques are anticipated to provide growth avenues to this market in the coming years. Since, 3D cultures closely mimic a typical organ microarchitecture and morphology, resembling the in-vivo model, there are substantial efforts taken towards developing in-vitro 3D cellular models.

A rise in demand for organ transplantation and tissue engineering for the treatment of chronic diseases is expected to drive research, impelling market growth through to 2027. Moreover, the advent of new technologies such as the lab-on-a-chip technique, based on the principle of microfabricated tissue component culturing, is anticipated to drive the market.

Further key findings from the report suggest:

• The scaffold based techniques segment accounted for a major share in 2019 and is projected to maintain its dominance throughout the forecast period

• Rising demand for three-dimensional cellular model-based research coupled with an increased incidence of chronic diseases is anticipated to propel market growth

• Hydrogels are the most commonly used scaffold-based methods. Therefore, the hydrogels segment occupied a major share of the scaffold-based technologies in 2019

• Enzymatically triggered peptide hydrogels for three-dimensional cell encapsulation and culture are expected to drive R&D in this segment

• The hanging drop microplates segment occupied a major share of the scaffold-free technologies used in these culture techniques

• This is because hanging drop microplates do not interfere with cell polarity and thus enable efficient cell growth in in vivo conditions

• Cancer was estimated to be the major application segment in 2019 and is expected to remain so throughout the forecast period

• Ongoing research to harness the potential of spheroid models for the development of new anticancer therapies is anticipated to drive R&D in the segment

• Adoption of three-dimensional cellular models for studying cancer biology in preclinical screening and testing as a result of the availability of customized microenvironments is expected to increase in the coming years

• Biotechnology and pharmaceutical organizations accounted for the largest share owing to a rise in the adoption of these culture techniques in drug discovery and tissue engineering

• Lucrative opportunities offered by emerging nations has attracted investments from global firms in the region, thus driving the 3D cell culture market in Asia Pacific region at the fastest growth rate throughout the forecast period

• Merck KGaA; Global Cell Solutions, Inc.; Thermo Fisher Scientific, Inc.; Corning, Inc.; PromoCell GmbH; Greiner Bio One International GmbH; 3D Biomatrix; 3D Biotek LLC; Lonza; Avantor Performance Materials, LLC; Tecan Trading AG; and InSphero are key players operating in this market

• These participants are engaged in new product development and strategic alliances to maintain the market share.

【レポートの目次】

Table Of Contents

Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 GVR’s internal database
2.1.3 Secondary sources:
2.1.4 Primary research:
2.1.5 Details of primary research
2.2 Information or Data Analysis
2.2.1 Data analysis models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity flow analysis (Model 1)
2.4.1.1 Approach 1: Commodity flow approach
2.4.2 Volume price analysis (Model 2)
2.4.2.1 Approach 2: Volume price analysis
2.5 List of Secondary Sources
2.6 List of Primary Sources
2.7 Objectives
2.7.1 Objective 1
2.7.2 Objective 2
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Market Segmentation & Scope
3.3 Definitions
3.3.1 Scaffold-based technology
3.3.1.1 Hydrogels
3.3.1.2 Polymeric scaffolds
3.3.1.3 Micropatterned surface microplates
3.3.1.4 Nanofiber Based Scaffolds
3.3.2 Scaffold-free technology
3.3.2.1 Hanging drop microplates
3.3.2.2 Microfluidic 3D cell culture
3.3.2.3 Spheroid microplates with ULA coating
3.3.2.4 Magnetic levitations & 3D bioprinting
3.3.3 Market driver analysis
3.3.3.1 Rising demand for organ transplantation & tissue engineering
3.3.3.2 Technological advancements in scaffold-free technology
3.3.3.3 Rise in investments and R&D funding for cell-based research
3.3.4 Market restraint analysis
3.3.4.1 High cost associated with implementation
3.3.4.2 Lack of compatibility and consistency
3.4 Penetration & Growth Prospect Mapping for Technology, 2019
3.5 3D Cell Culture Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.6 IndustryAnalysis – Porter’s
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & acquisitions
3.7.2 Product developments
3.7.3 Other deals
Chapter 4 Market Categorization: Technology Estimates & Trend Analysis
4.1 3D Cell Culture Market: Technology Movement Analysis
4.2 Scaffold Based
4.2.1 Global scaffold-based 3D cell culture market, 2016 – 2027 (USD Million)
4.2.2 Hydrogels
4.2.2.1 Global hydrogels market, 2016 – 2027 (USD Million)
4.2.3 Polymeric scaffolds
4.2.3.1 Global polymeric scaffolds market, 2016 – 2027 (USD Million)
4.2.4 Micropatterned surface microplates
4.2.4.1 Global micropatterned surface microplates market, 2016 – 2027 (USD Million)
4.2.5 Nanofiber based scaffolds
4.2.5.1 Global nanofiber based scaffolds market, 2016 – 2027 (USD Million)
4.3 Scaffold Free
4.3.1 Global scaffold free 3D cell culture market, 2016 – 2027 (USD Million)
4.3.2 Hanging drop microplates
4.3.2.1 Global hanging drop microplates market, 2016 – 2027 (USD Million)
4.3.3 Microfluidic 3D cell culture
4.3.3.1 Global microfluidic 3D cell culture market, 2016 – 2027 (USD Million)
4.3.4 Spheroid microplates with ULA coating
4.3.4.1 Global spheroid microplates with ULA coating market, 2016 – 2027 (USD Million)
4.3.5 Magnetic levitations & 3D bioprinting
4.3.5.1 Global magnetic levitations & 3D bioprinting market, 2016 – 2027 (USD Million)
4.4 Bioreactors
4.4.1 Global bioreactors market, 2016 – 2027 (USD Million)
Chapter 5 Market Categorization: Application Estimates & Trend Analysis
5.1 3D Cell Culture Market: Application Movement Analysis
5.2 Cancer
5.2.1 Global cancer market, 2016 – 2027 (USD Million)
5.3 Tissue Engineering & Immunohistochemistry
5.3.1 Global tissue engineering & immunohistochemistry market, 2016 – 2027 (USD Million)
5.4 Drug Development
5.4.1 Global drug development market, 2016 – 2027 (USD Million)
5.5 Stem Cell Research
5.5.1 Global stem cell research market, 2016 – 2027 (USD Million)
5.6 Others
5.6.1 Global other applications market, 2016 – 2027 (USD Million)
Chapter 6 Market Categorization: End-use Estimates & Trend Analysis
6.1 3D Cell Culture Market: End-use Movement Analysis
6.2 Biotechnology and Pharmaceutical Industries
6.2.1 Global biotechnology and pharmaceutical industries market, 2016 – 2027 (USD Million)
6.3 Research Laboratories and Institutes
6.3.1 Global research laboratories and institutes market, 2016 – 2027 (USD Million)
6.4 Hospitals and Diagnostic Centers
6.4.1 Global hospitals and diagnostic centers market, 2016 – 2027 (USD Million)
6.5 Others
6.5.1 Global other end-use market, 2016 – 2027 (USD Million)
Chapter 7 Market Categorization: Regional Estimates & Trend Analysis by Technology, Application & End Use
7.1 3D Cell Culture Market: Regional Movement Analysis
7.2 3D Cell Culture Market Share by Region, 2019 & 2027
7.3 North America
7.3.1 North America 3D cell culture market, 2016 – 2027 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. 3D cell culture market, by technology, 2016 – 2027 (USD Million)
7.3.2.2 U.S. 3D cell culture market, by application, 2016 – 2027 (USD Million)
7.3.2.3 U.S. 3D cell culture market, by end use, 2016 – 2027 (USD Million)
7.3.3 Canada
7.3.3.1 Canada 3D cell culture market, by technology, 2016 – 2027 (USD Million)
7.3.3.2 Canada 3D cell culture market, by application, 2016 – 2027 (USD Million)
7.3.3.3 Canada 3D cell culture market, by end use, 2016 – 2027 (USD Million)
7.4 Europe
7.4.1 Europe 3D cell culture market, 2016 – 2027 (USD Million)
7.4.2 Germany
7.4.2.1 Germany 3D cell culture market, by technology, 2016 – 2027 (USD Million)
7.4.2.2 Germany 3D cell culture market, by application, 2016 – 2027 (USD Million)
7.4.2.3 Germany 3D cell culture market, by end use, 2016 – 2027 (USD Million)
7.4.3 U.K.
7.4.3.1 U.K. 3D cell culture market, by technology, 2016 – 2027 (USD Million)
7.4.3.2 U.K. 3D cell culture market, by application, 2016 – 2027 (USD Million)
7.4.3.3 U.K. 3D cell culture market, by end use, 2016 – 2027 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific 3D cell culture market, 2016 – 2027 (USD Million)
7.5.2 Japan
7.5.2.1 Japan 3D cell culture market, by technology, 2016 – 2027 (USD Million)
7.5.2.2 Japan 3D cell culture market, by application, 2016 – 2027 (USD Million)
7.5.2.3 Japan 3D cell culture market, by end use, 2016 – 2027 (USD Million)
7.5.3 China
7.5.3.1 China 3D cell culture market, by technology, 2016 – 2027 (USD Million)
7.5.3.2 China 3D cell culture market, by application, 2016 – 2027 (USD Million)
7.5.3.3 China 3D cell culture market, by end use, 2016 – 2027 (USD Million)
7.6 Latin America
7.6.1 Latin America 3D cell culture market, 2016 – 2027 (USD Million)
7.6.2 Brazil
7.6.2.1 Brazil 3D cell culture market, by technology, 2016 – 2027 (USD Million)
7.6.2.2 Brazil 3D cell culture market, by application, 2016 – 2027 (USD Million)
7.6.2.3 Brazil 3D cell culture market, by end use, 2016 – 2027 (USD Million)
7.7 Middle East & Africa (MEA)
7.7.1 MEA 3D cell culture market, 2016 – 2027 (USD Million)
7.7.2 South Africa
7.7.2.1 South Africa 3D cell culture market, by technology, 2016 – 2027 (USD Million)
7.7.2.2 South Africa 3D cell culture market, by application, 2016 – 2027 (USD Million)
7.7.2.3 South Africa 3D cell culture market, by end use, 2016 – 2027 (USD Million)
Chapter 8 Competitive Landscape
8.1 Market Participation Categorization
8.2 Technology offerings of key players in 3D cell culture market
8.3 Company Profiles
8.3.1 Merck KGaA
8.3.1.1 Company overview
8.3.1.2 Sigma-Aldrich Co. LLC
8.3.1.2.1 Company overview
8.3.1.3 Financial performance
8.3.1.3.1 Financial performance
8.3.1.4 Product benchmarking
8.3.1.5 Strategic initiatives
8.3.2 Thermo Fisher Scientific, Inc.
8.3.2.1 Company overview
8.3.2.2 Becton, Dickinson and Company (BD)
8.3.2.2.1 Company overview
8.3.2.3 Financial performance
8.3.2.3.1 Financial performance
8.3.2.4 Product benchmarking
8.3.2.5 Strategic initiatives
8.3.3 PromoCell GmbH
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Greiner Bio One International GmbH
8.3.4.1 Company overview
8.3.4.2 Nano3D Biosciences, Inc.
8.3.4.2.1 Company overview
8.3.4.3 Financial performance
8.3.4.4 Product benchmarking
8.3.4.5 Strategic initiatives
8.3.5 Corning, Inc.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 3D Biomatrix
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Lonza
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Avantor Performance Materials, LLC
8.3.8.1 Company overview
8.3.8.2 VWR International, LLC
8.3.8.2.1 Company overview
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Tecan Trading AG.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 3D Biotek LLC
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 Global Cell Solutions, Inc.
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.12 InSphero
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic Initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 Technical attributes for scaffolds
TABLE 3 Technical attributes for hydrogels
TABLE 4 Technical attributes for scaffold-free techniques
TABLE 5 Overview of Scaffold-based 3D techniques and their attributes
TABLE 6 Overview of Scaffold-free techniques and their attributes
TABLE 7 Cancer incidence and mortality, by region, 2018
TABLE 8 North America 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 9 North America scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 10 North America scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 11 North America 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 12 North America 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 13 U.S. 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 14 U.S. scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 15 U.S. scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 16 U.S. 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 17 U.S. 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 18 Canada 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 19 Canada scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 20 Canada scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 21 Canada 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 22 Canada 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 23 Europe 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 24 Europe scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 25 Europe scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 26 Europe 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 27 Europe 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 28 Germany 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 29 Germany scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 30 Germany scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 31 Germany 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 32 Germany 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 33 U.K. 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 34 U.K. scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 35 U.K. scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 36 U.K. 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 37 U.K. 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 38 Asia Pacific 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 39 Asia Pacific scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 40 Asia Pacific scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 41 Asia Pacific 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 42 Asia Pacific 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 43 Japan 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 44 Japan scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 45 Japan scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 46 Japan 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 47 Japan 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 48 China 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 49 China scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 50 China scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 51 China 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 52 China 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 53 Latin America 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 54 Latin America scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 55 Latin America scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 56 Latin America 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 57 Latin America 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 58 Brazil 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 59 Brazil scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 60 Brazil scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 61 Brazil 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 62 Brazil 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 63 MEA 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 64 MEA scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 65 MEA scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 66 MEA 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 67 MEA 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)
TABLE 68 South Africa 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 69 South Africa scaffold based 3D cell culture market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 70 South Africa scaffold free 3D cell culture market estimates & forecasts, by technology 2016 - 2027 (USD Million)
TABLE 71 South Africa 3D cell culture market estimates & forecasts, by application 2016 - 2027 (USD Million)
TABLE 72 South Africa 3D cell culture market estimates & forecasts, by end use 2016 - 2027 (USD Million)

★調査レポート[3D細胞培養の世界市場:技術別(スキャフォールドベース、スキャフォールドフリー、バイオリアクター)、用途別(がん、医薬品開発)、最終用途別、地域別] (コード:GVR20MA084)販売に関する免責事項を必ずご確認ください。
★調査レポート[3D細胞培養の世界市場:技術別(スキャフォールドベース、スキャフォールドフリー、バイオリアクター)、用途別(がん、医薬品開発)、最終用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆